Уважаемые коллеги!
Это старая версия сайта Российского кардиологического общества.
Страница не обновляется. Архив событий и новостей.
Для актуальной информации пройдите на scardio.ru

UEFA Cup in the Hands of GUARANT International

20.10.20132197
The most important sports event of this summer was undoubtedly the 2013 UEFA Super Cup, which on the 30th of August had been hosted at Prague‘s Eden stadium.

Are Guidelines Followed Less When Treating Secondary Diagnosis of HF?

18.10.20131750
The quality of care for hospitalized heart failure (HF) patients could be dramatically improved with one change — extending the same standard of care to patients with HF as a secondary diagnosis that is currently recommended for patients with HF as a primary diagnosis, according to a study published in the Journal of the American College of Cardiology.

IBD Tied to Higher Risk for Heart Trouble

17.10.20131878
Inflammatory bowel disease (IBD) was associated with increased risks for stroke, myocardial infarction (MI), and ischemic heart disease, particularly in women, researchers reported.

Residential exposure to aircraft noise and hospital admissions for cardiovascular diseases: multi-airport retrospective study

16.10.20131909
To investigate whether exposure to aircraft noise increases the risk of hospitalization for cardiovascular diseases in older people (?65 years) residing near airports.

Skeletal muscle morphology and risk of cardiovascular disease in elderly men

15.10.20131779
While it is well known that physical inactivity is a major risk factor for cardiovascular disease, there is still a search for the mechanisms by which exercise exerts its positive effect.

Early short-term doxycycline therapy in patients with acute myocardial infarction and left ventricular dysfunction to prevent the ominous progression to adverse remodelling: the TIPTOP trial

14.10.20131818
Experimental studies suggest that doxycycline attenuates post-infarction remodelling and exerts protective effects on myocardial ischaemia/reperfusion injury.

Optimal Duration of Dual Antiplatelet Therapy after Drug-Eluting Stent Implantation: A Randomized Controlled Trial

11.10.20131830
The risks and benefits of long-term dual antiplatelet therapy remain unclear.
Данный сайт и вся информация на нём предназначена для медицинских работников. Продолжая просмотр, вы соглашаетесь и подтверждаете, что являетесь медицинским работником.